Herborium® Group Inc. Unique Herbal Acne Treatment - AcnEase® to Enter Pacific Asian Markets

December 08 2020

December 8, 2020. Herborium® Group, Inc. (OTC Pink: HBRM),  www.Herborium.com, www.acnease.com a Botanical Therapeutics® Company and the provider of proprietary all botanical medicinal products (Botanical Therapeutics®) and interactive advanced content targeting dermatological issues such as acne and Rosacea, and other health and wellness concerns, is happy to announce its unique herbal acne treatment -AcnEase® to enter the fastest growing Asia Pacific market.

As the global dietary supplements market is poised to grow by $26.7 billion during the period spanning 2020-2024, the major shift lies in where this growth will come from. In 2017, 31% of the world’s consumer disposable income originates from Asia. By 2030, Asia is expected to add an additional USD12 trillion in disposable income, which is almost 55% of the global increment. The Asian skincare market is expected to grow by 6% by 2022.

To harness this opportunity, in November 2020 Herborium ®signed a master distribution agreement with Phinix Global Pte. Ltd. (“Phinix”).  Phinix Global Pte. Ltd. is a part of GPS Alliance Holdings Limited (AU:GPS) which is listed on the Sydney Stock Exchange. GPS has extensive reach throughout South East Asia . In addition to marketing and distributing Herborium’s products Herborium and GPS are presently discussing additional near - term partnerships to foster growth in the US and Asia.  Phinix is presently in the process of registering Herborium’s products in Singapore to make them ready for a rollout in Asian markets in the second quarter of 2021.

About Herborium Group, Inc.

Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company’s business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements).  The Company uses clinical validation and a proactive regulatory strategy based to establish and maintain a differential advantage.  Herborium has secured a pipeline of botanical ingredients based products Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com , www.acnease.fr,   and www.acneaseeu.com

Safe Harbor Statement:  This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties.  The Company's actual future results could materially differ from those discussed.   The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:
Herborium Group, Inc.
Email: InvestorRelations@Herborium.com  or DrAgnes@Herborium.com